Clinical Trials

Sathgen aims to develop MSP008-22 for difficult-to-treat cancers, starting with triple negative breast cancer (TNBC) and prostate…

Jahanara Nayar Rahuldev, Diversity Equity Inclusion India Lead, Parexel accentuates that diversity, equity and inclusion in…

Lupin and AbbVie inked the licensing, development, and commercialisation agreement in 2018 for this novel oncology drug to treat…

Musk envisions brain implants could cure a range of conditions including obesity, autism, depression and schizophrenia as well as…

This ASP-1929-301 study is currently underway in several countries such as the US and Taiwan, and will enroll 275 patients…

Based on the status of Phase I/II clinical trials of BB-1701 currently being conducted by BlissBio, both companies have decided to…

Shivajyoti Bhattacharjee, VP – Healthcare & Life Sciences, Cybage Software highlights how RWD and RWE are pivotal to clinical…

Sun Pharma acquired deuruxolitinib when it bought Concert Pharmaceuticals for $576 million earlier this year

Improvement in overall survival was one of the study's dual main goals, according to Merck and Eisai

Deepak Gandotra, Senior Director, Enterprise Clinical Solutions, Indegene, believes the new year will see a stronger coupling…